Antibiotic use in public hospitals in Vietnam between 2018 and 2022: a retrospective study.
BMJ Open
; 14(8): e087322, 2024 Aug 09.
Article
em En
| MEDLINE
| ID: mdl-39122394
ABSTRACT
OBJECTIVE:
To assess the patterns of antibiotic consumption and expenditure in Vietnam.DESIGN:
This was a cross-sectional study.SETTING:
This study used data of antibiotic procurement that was publicly announced from 2018 to 2022 as a proxy for antibiotic consumption.PARTICIPANTS:
This study included winning bids from 390 procurement units in 63 provinces in Vietnam for 5 years with a total expenditure of US$ 12.8 billions that represented for approximately 20-30% of the national funds spend on medicines.INTERVENTIONS:
Antibiotics were classified by WHO AWaRe (Access, Watch and Reserve) classification. OUTCOMEMEASURES:
The primary outcomes were the proportions of antibiotic consumptions in number of defined daily doses (DDD) and expenditures.RESULTS:
There was a total of 2.54 million DDDs of systemic antibiotics, which accounted for 24.7% (US $3.16 billions) of total expenditure for medicines purchased by these public health facilities. The overall proportion of Access group antibiotics ranges from 40.9% to 53.8% of the total antibiotic consumption over 5 years.CONCLUSION:
This analysis identifies an unmet target of at least 60% of the total antibiotic consumption being Access group antibiotics and an unreasonable share of expenditure for non-essential antibiotics in public hospitals in Vietnam.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Hospitais Públicos
/
Antibacterianos
Limite:
Humans
País/Região como assunto:
Asia
Idioma:
En
Revista:
BMJ Open
Ano de publicação:
2024
Tipo de documento:
Article
País de publicação:
Reino Unido